Close
Achema middle east
swop processing & packaging

Drug Research

University team uses AI to decode asbestos-linked cancer

Researchers at the University of Leicester have used artificial intelligence (AI) to gain new insights into mesothelioma, a cancer caused by breathing asbestos particles that...

Moderna Announces New Supply Agreement with the Philippines for...

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that the Philippines has secured 7 million additional doses of COVID-19 Vaccine...

Evotec and Takeda enter strategic RNA targeting drug discovery...

Evotec SE announced that the Company has entered into a multi-RNA target alliance with Takeda Pharmaceutical Company Limited (“Takeda”) with the goal to discover and...

RDIF and Virchow Biotech partner for production of Sputnik...

The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), and Virchow Biotech Private Limited (part of the Virchow Group), one of the leading vaccine...

Boston Pharmaceuticals Enters into Unique Multi-Year Out-License and Option...

Boston Pharmaceuticals announced a pioneering three-year out-license and option agreement with GlaxoSmithKline PLC. Boston Pharmaceuticals will become a preferred GSK partner for select pre-phase 2...

US FDA approves Janssen’s PONVORY for relapsing multiple sclerosis

The US FDA has approved the Janssen Pharmaceutical Companies of Johnson & Johnson’s (JNJ) PONVORY (ponesimod) for treating adults with relapsing forms of multiple sclerosis...

Gilead and Novo Nordisk Expand NASH Clinical Collaboration

Gilead Sciences, Inc. and Novo Nordisk A/S announced that the companies have expanded their clinical collaboration in non-alcoholic steatohepatitis (NASH). The companies will conduct a Phase...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »